Web Stats Provided By Google Analytics

Thursday, April 24, 2014

FDA Advisors Reject Combination Pain Pill Moxduo

The FDA's Anesthetic and Analgesic Products Advisory Committee has voted unanimously to reject Moxduo , an investigational pain pill that combines two common opioids, oxycodone hydrochloride and morphine sulfate.

http://ift.tt/1jSMxSD

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts